On Monday, Shares of The Wendy’s Company (NASDAQ:WEN), gained 3.15% to $10.47.
The Wendy’s Company, declared the declaration of its regular quarterly cash dividend of $0.055 per share, payable on June 15, 2015, to shareholders of record as of June 1, 2015.
The approximate number of common shares outstanding as of April 30, 2015 was 363.2 million.
The Wendy’s Company, through its auxiliaries, owns and franchises Wendy’s restaurant system. The company is involved in operating, developing, and franchising a system of quick-service restaurants.
At the end of Monday’s trade, Shares of Cooper Tire & Rubber Co. (NYSE:CTB), jumped 3.12% to $38.06.
Cooper Tire & Rubber Company, declared that net income attributable to Cooper Tire & Rubber Company was $41 million, or $0.69 per share, contrast with $45 million, or $0.71 per share, last year. Net sales were $663 million contrast with $796 million in the first quarter of 2014. The sales decline was more than attributable to the absence of CCT, the company’s former joint venture in China, which was divested in the fourth quarter of 2014. CCT contributed $157 million to net sales, net of intercompany eliminations, in the first quarter of 2014. Not taking into account CCT, first quarter 2015 sales rose 4 percent as a result of higher unit volume of $35 million, which was partially offset by negative foreign exchange of $7 million.
First quarter 2015 operating profit was $70 million contrast with $81 million for the same period last year, which comprised of $21 million from CCT. First quarter operating margin was 10.6 percent as compared to 10.2 percent in 2014. Not taking into account the impact of CCT, operating profit raised $10 million from favorable raw material costs of $46 million and higher volume of $4 million. These benefits were partially offset by $16 million of higher manufacturing costs, unfavorable price and mix of $15 million, higher product liability costs of $4 million, higher selling, general and administrative (SG&A) costs of $3 million, and an enhance in other costs of $2 million, counting negative foreign exchange impact.
The effective tax rate for the first quarter, counting discrete items, was 34.8 percent contrast with 30.4 percent last year. The rate in 2015 is higher due to the mix of income, and is based on forecasted annual earnings and tax rates for various tax jurisdictions. SG&A expense for the quarter was $62 million, or 9.3 percent of sales, contrast with $66 million, or 8.3 percent of sales, in the first quarter of 2014. SG&A expense in the first quarter of 2015 was influenced by unfavorable mark-to-market costs of stock-based liabilities of $4 million.
Cooper Tire & Rubber Company, together with its auxiliaries, manufactures and markets replacement tires worldwide. The company operates in two segments, Americas Tire Operations and International Tire Operations.
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP), ended its last trade with 3.11% gain, and closed at $3.65.
Synergy Pharmaceuticals, declared that its Chairman and Chief Executive Officer, Gary S. Jacob, Ph.D., will present a corporate update at the UBS Global Healthcare Conference on Wednesday May 20th at 12:00pm (EDT) at the Sheraton New York Times Square Hotel in New York City.
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders.
Finally, Centene Corp. (NYSE:CNC), closed at $64.83, with 3.07% gain.
Centene Corporation, declared it will present at two forthcoming healthcare conferences in May.
At the Bank of America Merrill Lynch 2015 Health Care Conference, to be held at the Encore at Wynn in Las Vegas, Nevada, on May 12-14, 2015, Centene’s presentation is planned for Thursday, May 14th at 9:20 a.m. Pacific Time.
Centene Corporation operates as a diversified, multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates in two segments, Managed Care and Specialty Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
